Vancomycin redistribution: dosing recommendations following high-flux hemodialysis

Kidney International
T A PollardB J Maroni

Abstract

Although increased vancomycin clearance has been reported with highly permeable hemodialysis membranes (such as polysulfone), failure to consider post-dialysis redistribution could lead to unnecessary dosage supplementation. In protocol 1, twelve hemodialysis patients admitted for vascular access thrombectomy received 15 mg/kg of vancomycin as surgical prophylaxis. Post-operatively, patients underwent high-flux hemodialysis (HFHD) for two hours using a Fresenius F-80 polysulfone dialyzer (QB = 417 +/- 49, QD = 800 ml/min). Vancomycin's intradialytic clearance increased 13-fold compared to the patient's endogenous clearance (120 +/- 59 vs. 9 +/- 8 ml/min, respectively) yet dialysate recovery indicated that only 17% of body stores were removed (179 +/- 70 mg). Although serum vancomycin levels decreased 33% during HFHD, vancomycin levels increased in all patients following dialysis and the post-rebound values reached 87% of the pre-dialysis concentration. In protocol 2, eight outpatients receiving maintenance HFHD with a F-80 dialyzer (Kt/V = 1.29 +/- 0.08) were given 20 mg/kg of vancomycin immediately following dialysis on Monday; pre- and post-levels were measured during the next three dialysis treatments. The predialysis serum ...Continue Reading

References

Apr 1, 1977·The American Journal of Medicine·G Levy
Oct 1, 1992·American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation·C A DeSoiJ G Umans
Jan 1, 1992·European Journal of Clinical Pharmacology·J BöhlerP J Schollmeyer
Sep 1, 1985·Kidney International·F A Gotch, J A Sargent
Jul 26, 1969·Lancet·A Amdisen, H Skjoldborg
May 12, 1966·The New England Journal of Medicine·D D Lindholm, J S Murray
Mar 1, 1981·Annals of Internal Medicine·R C MoelleringD J Greenblatt
May 1, 1984·American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation·J A ZiemniakJ J Schentag
Apr 1, 1984·Antimicrobial Agents and Chemotherapy·Gary R MatzkeW F Keane
Oct 1, 1982·Journal of Pharmacokinetics and Biopharmaceutics·K K Chan, M Gibaldi
Nov 1, 1981·Reviews of Infectious Diseases·B A CunhaC H Nightingale

Citations

Jun 22, 2011·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Merideth BrownHans P Schlecht
Feb 7, 2008·Seminars in Dialysis·Katie E Pallotta, Harold J Manley
Jan 5, 2013·The Canadian Journal of Hospital Pharmacy·Wasim S El NekidyMichelle Dehoorne-Smith
Jun 5, 2012·Biomedical Papers of the Medical Faculty of the University Palacký, Olomouc, Czechoslovakia·Nadezda PetejovaIvana Kacirova
Jul 15, 2015·Expert Review of Anti-infective Therapy·Karl Evans R HensonDonald P Levine
Nov 24, 1999·Kidney International. Supplement·W R Clark, Claudio Ronco
Sep 1, 1996·Kidney International·R H Barth, N DeVincenzo
Aug 26, 2004·British Journal of Clinical Pharmacology·Megan E DelDotSusan E Tett
Jan 29, 2016·Journal of Pharmaceutical Health Care and Sciences·Gaku AkashitaYoshimichi Sai
Jan 15, 2013·International Journal of Antimicrobial Agents·Cecilia CovajesFabio Silvio Taccone
Jan 12, 2000·The Annals of Pharmacotherapy·P F Smith, G D Morse
Jan 31, 2018·Hemodialysis International·Heather A NymanAlfred K Cheung
Sep 29, 2011·ASAIO Journal : a Peer-reviewed Journal of the American Society for Artificial Internal Organs·Kostas I SombolosChristina I Fytili
Feb 18, 1998·Clinical Pharmacology and Therapeutics·F Schaedeli, D E Uehlinger
Jun 25, 2008·American Journal of Health-system Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists·Brooke S CrawfordJohn J Doran
Oct 23, 2015·American Journal of Health-system Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists·Page CrewBrett H Heintz
Jun 13, 2020·PloS One·Masaki FukunagaSumio Hirata
Mar 18, 2017·Circulation Journal : Official Journal of the Japanese Circulation Society·Kazutaka AonumaJapanese Circulation Society and the Japanese Society of Therapeutic Drug Monitoring Joint Working Group
Sep 15, 2018·The Journal of Antimicrobial Chemotherapy·Katrina HuiCarl M J Kirkpatrick
Apr 1, 1994·The Annals of Pharmacotherapy·Gary R Matzke

Related Concepts

Implantable Catheters
Dose-Response Relationship, Drug
Hemodialysis
Osmolality
Preoperative Procedure
Drug or Chemical Tissue Distribution
AB-Vancomycin
Thrombectomy

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Lipidomics & Rhinovirus Infection

Lipidomics can be used to examine the lipid species involved with pathogenic conditions, such as viral associated inflammation. Discovered the latest research on Lipidomics & Rhinovirus Infection.

Alzheimer's Disease: MS4A

Variants within the membrane-spanning 4-domains subfamily A (MS4A) gene cluster have recently been implicated in Alzheimer's disease in genome-wide association studies. Here is the latest research on Alzheimer's disease and MS4A.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Torsion Dystonia

Torsion dystonia is a movement disorder characterized by loss of control of voluntary movements appearing as sustained muscle contractions and/or abnormal postures. Here is the latest research.

Generating Insulin-Secreting Cells

Reprogramming cells or using induced pluripotent stem cells to generate insulin-secreting cells has significant therapeutic implications for diabetics. Here is the latest research on generation of insulin-secreting cells.

Central Pontine Myelinolysis

Central Pontine Myelinolysis is a neurologic disorder caused most frequently by rapid correction of hyponatremia and is characterized by demyelination that affects the central portion of the base of the pons. Here is the latest research on this disease.

Epigenome Editing

Epigenome editing is the directed modification of epigenetic marks on chromatin at specified loci. This tool has many applications in research as well as in the clinic. Find the latest research on epigenome editing here.

Related Papers

Antimicrobial Agents and Chemotherapy
J M QualeR H Barth
Critical Care : the Official Journal of the Critical Care Forum
Eric A J Hoste, Annemieke Dhondt
American Journal of Health-system Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists
Brooke S CrawfordJohn J Doran
© 2021 Meta ULC. All rights reserved